Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lianbo Burn Ointment (连柏烧伤软膏) is a traditional Chinese medicine (TCM) topical treatment developed and manufactured by Guangdong Zhanjiang Jimin Pharmaceutical. It is an approved pharmaceutical product indicated for the treatment of burn wounds and general skin wound care. The ointment is formulated to clear heat, detoxify the skin, reduce swelling, and alleviate pain associated with first and second-degree burns. As a TCM formulation, it typically utilizes the pharmacological properties of herbal ingredients such as *Coptis chinensis* (Huanglian) and *Phellodendron amurense* (Huangbai), which are rich in alkaloids like berberine that provide antimicrobial and anti-inflammatory effects to promote wound healing and prevent infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lianbo Burn Ointment.